Ohr Pharmaceutical, Inc.
Records under this name other than patents Ohr Pharmaceutical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Ohr Pharmaceutical, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,981,876 | Polymorphic and amorphous salt forms of squalamine dilactate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,546,194 | Aminosteroids for the treatment of a PTP1B associated disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,556,923 | Aminosteroids for the treatment of a PTP1B associated disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,434,257 | Aminosteroids for the Treatment of a PTP1B Associated Disease Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,716,270 | Polymorphic and amorphous salt forms of squalamine dilactate Formerly held Lapsed on the fee record Ended May 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2026 | From the USPTO record |
| US 7,728,157 | Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols Lapsed on the fee record Ended Jun 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 1, 2022 | From the USPTO record |
| US 7,074,778 | Asthma associated factors as targets for treating atopic allergies including asthma and related disorders Term ended Term ended May 30, 2021 · From the USPTO record | Term ended | Term ended May 30, 2021 | From the USPTO record |
| US 6,933,383 | Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols Term ended Term ended Apr 12, 2021 · From the USPTO record | Term ended | Term ended Apr 12, 2021 | From the USPTO record |
| US 7,410,959 | Therapeutic uses for aminosterol compounds Lapsed on the fee record Ended Aug 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 12, 2020 | From the USPTO record |
| US 8,987,236 | Therapeutic uses for an aminosterol compound Term ended Term ended Jul 13, 2020 · From the USPTO record | Term ended | Term ended Jul 13, 2020 | From the USPTO record |